Biome Australia Limited (BIO.AX)
AUD 0.47
(-5.05%)
AUD 0.47
(-5.05%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 7.66 Million AUD | 95.09% |
| 2023 | 4.05 Million AUD | 70.55% |
| 2022 | 2.37 Million AUD | 121.83% |
| 2021 | 1.07 Million AUD | 363.58% |
| 2020 | 231.21 Thousand AUD | 4.39% |
| 2019 | 221.49 Thousand AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 3.49 Million AUD | 93.15% |
| 2024 FY | 7.66 Million AUD | 89.13% |
| 2024 Q4 | 4.17 Million AUD | 0.0% |
| 2024 Q1 | 1.81 Million AUD | -16.17% |
| 2023 Q2 | 1.89 Million AUD | 90.03% |
| 2023 FY | 4.05 Million AUD | 70.55% |
| 2023 Q4 | 2.16 Million AUD | 89.4% |
| 2023 Q3 | 1.14 Million AUD | -39.75% |
| 2023 Q1 | 996.7 Thousand AUD | -22.4% |
| 2022 Q1 | 520.26 Thousand AUD | -15.32% |
| 2022 FY | 2.37 Million AUD | 121.83% |
| 2022 Q4 | 1.28 Million AUD | 90.76% |
| 2022 Q3 | 673.32 Thousand AUD | -33.93% |
| 2022 Q2 | 1.01 Million AUD | 95.89% |
| 2021 Q3 | 343.82 Thousand AUD | -24.84% |
| 2021 Q4 | 614.41 Thousand AUD | 78.7% |
| 2021 FY | 1.07 Million AUD | 363.58% |
| 2021 Q1 | 245.74 Thousand AUD | 0.0% |
| 2021 Q2 | 457.43 Thousand AUD | 86.14% |
| 2020 FY | 231.21 Thousand AUD | 4.39% |
| 2019 FY | 221.49 Thousand AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AdAlta Limited | 1.5 Million AUD | -408.627% |
| Acrux Limited | -1.28 Million AUD | 697.326% |
| Amplia Therapeutics Limited | 4.01 Million AUD | -91.228% |
| BTC Health Limited | 16.36 Thousand AUD | -46780.568% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | -2.897% |
| CSL Limited | 15.28 Billion AUD | 99.95% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 33.346% |
| Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | 90.179% |
| Noxopharm Limited | -534.81 Thousand AUD | 1534.088% |
| PharmAust Limited | -1641.00 AUD | 467477.27% |
| Proteomics International Laboratories Limited | -1.12 Million AUD | 782.847% |
| Prescient Therapeutics Limited | 3.71 Million AUD | -106.598% |
| PYC Therapeutics Limited | 22.05 Million AUD | 65.232% |
| Race Oncology Limited | 1.38 Million AUD | -451.808% |
| Starpharma Holdings Limited | 7.65 Million AUD | -0.165% |
| EZZ Life Science Holdings Limited | 50.94 Million AUD | 84.945% |
| Botanix Pharmaceuticals Limited | -6.55 Million AUD | 217.067% |
| Memphasys Limited | 1606.00 AUD | -477462.951% |
| Nyrada Inc. | -5164.07 AUD | 148619.695% |
| Anatara Lifesciences Ltd | -748.91 Thousand AUD | 1124.11% |
| Telix Pharmaceuticals Limited | 308.5 Million AUD | 97.514% |
| Bio-Gene Technology Limited | -301.44 Thousand AUD | 2644.265% |
| Zelira Therapeutics Limited | 10.28 Thousand AUD | -74478.578% |
| Patrys Limited | 1.39 Million AUD | -450.127% |
| Dimerix Limited | 583.47 Thousand AUD | -1214.473% |
| Neuren Pharmaceuticals Limited | 205.17 Million AUD | 96.262% |
| Orthocell Limited | 3.68 Million AUD | -107.939% |
| Imugene Limited | -5.83 Million AUD | 231.333% |
| Cynata Therapeutics Limited | 2.31 Million AUD | -231.211% |
| Immutep Limited | 1.44 Million AUD | -431.175% |
| Arovella Therapeutics Limited | -25.97 Thousand AUD | 29622.541% |
| Alterity Therapeutics Limited | 3.8 Million AUD | -101.569% |
| Nanollose Limited | -348.95 Thousand AUD | 2297.913% |
| Invex Therapeutics Ltd | 1.21 Million AUD | -532.677% |
| NeuroScientific Biopharmaceuticals Limited | -91.33 Thousand AUD | 8497.102% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | -512.801% |
| Biotron Limited | -40.49 Thousand AUD | 19038.37% |
| Radiopharm Theranostics Limited | -21.3 Million AUD | 135.994% |
| Tissue Repair Ltd | 150.51 Thousand AUD | -4995.748% |
| AnteoTech Limited | 460.39 Thousand AUD | -1565.88% |
| Hexima Limited | - AUD | -Infinity% |
| Paradigm Biopharmaceuticals Limited | 56.81 Thousand AUD | -13400.072% |
| Recce Pharmaceuticals Ltd | -366.76 Thousand AUD | 2191.148% |
| Avecho Biotechnology Limited | -43.79 Thousand AUD | 17612.641% |
| Actinogen Medical Limited | 9.93 Million AUD | 22.774% |
| Immuron Limited | 3.33 Million AUD | -129.851% |
| Argenica Therapeutics Limited | 2.59 Million AUD | -195.221% |